New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 7, 2011
09:30 EDTADATAuthentidate sells $4.1M of shares at 70c in registered direct offering
Authentidate announced that it has entered into definitive agreements with institutional and accredited investors for a direct placement of $4,112,500 of common stock and warrants, at a unit price of 70c per share and warrant. The warrants will be exercisable commencing on the six month anniversary of the date on which they are issued and have an exercise price of $1.00 per share. The warrants will expire on the 4 year anniversary of the initial exercise date. C.K. Cooper and Rodman & Renshaw served as co-placement agents for this offering.
News For ADAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2015
06:53 EDTADATAuthentidate, AEON Clinical Laboratories enter non-binding LOI to merge
Authentidate Holding and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories, an expanding clinical laboratory based in Gainesville, GA, announced that the companies have entered into a non-binding letter of intent, or LOI, for the acquisition of all of the outstanding membership interests of AEON in exchange for shares of a newly created class of Series E Preferred Stock of Authentidate. The Letter of Intent contemplates the AEON members will be issued such number of Series E Shares as shall be convertible into 19.9% of the outstanding shares of the company's Common Stock on the date of the closing of the merger transaction, and an additional 5% of the outstanding shares of the company's Common Stock upon approval of the merger transaction by the shareholders of the company. Additional Series E Shares will be issued to AEON members in 2016 and 2020 if AEON achieves certain financial results. The additional 2016 Series E Shares will be convertible into 24% of the outstanding shares of the company's Common Stock on the date of the closing and will be issued to the AEON members provided AEON achieves $16M of EBITDA in calendar year 2015. The AEON members will be issued another tranche of Series E Shares in 2020 which, including the previously issued Series E Shares, will be convertible into 85% of the outstanding shares of the company's Common Stock provided AEON achieves $65.9M in EBITDA, in the aggregate, in calendar years 2017 and 2018, or $99M in EBITDA, in the aggregate, for calendar years 2016, 2017 and 2018. The Letter of Intent also provides for the issuance of Series E Shares as bonus shares for the achievement of $117 million in net income for the four fiscal years ending December 31, 2019, convertible into 5% of the outstanding shares of the company's Common Stock. The holders of the Series E Shares will have certain preferential rights, including the right to vote separately as a class to nominate and elect one director for each 10% of the outstanding shares of Authentidate's Common Stock into which the outstanding Series E Shares shall be convertible.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use